Evidence map›Paper›PMID 35059840›Full record

ArticleSurgical endoscopy2022

Feasibility of endoscopic resection without laparoscopic assistance for giant gastric subepithelial tumors originating from the muscularis propria layer (with video).

Yu Zhang, Qian Meng, Xian-Bin Zhou, Guang Chen, Lin-Hong Zhu, Xin-Li Mao, Li-Ping Ye

Abstract readVideo-Audio Media
PubMed Publisher
In one paragraph

Article in Surgical endoscopy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. [Diagnosis and Management of Asymptomatic Upper Gastrointestinal Subepithelial Lesions].The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2026
    Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Yu ZhangDepartment of Gastroenterology, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University; Key Laboratory of Minimally Invasive Techniques & Rapid Rehabilitation of Digestive System Tumor of Zhejiang Province, 150 Ximen Street, Linhai, Zhejiang, China.
Qian MengShaoxing University School of Medicine, Shaoxing, Zhejiang, China.
Xian-Bin ZhouDepartment of Gastroenterology, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University; Key Laboratory of Minimally Invasive Techniques & Rapid Rehabilitation of Digestive System Tumor of Zhejiang Province, 150 Ximen Street, Linhai, Zhejiang, China.
Guang ChenDepartment of General Surgery, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, China.
Lin-Hong ZhuDepartment of Medical Administration, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, China.
Xin-Li Mao *Department of Gastroenterology, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University; Key Laboratory of Minimally Invasive Techniques & Rapid Rehabilitation of Digestive System Tumor of Zhejiang Province, 150 Ximen Street, Linhai, Zhejiang, China. maoxl75@126.com.
Li-Ping Ye *Department of Gastroenterology, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University; Key Laboratory of Minimally Invasive Techniques & Rapid Rehabilitation of Digestive System Tumor of Zhejiang Province, 150 Ximen Street, Linhai, Zhejiang, China. xmcx783@126.com.ORCID 0000-0002-7938-0960
Wenzhou Medical University · CNShaoxing University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimsCurrently, published data of endoscopic resection (ER) for giant (≥ 6 cm) gastric subepithelial tumors originating from the muscularis propria layer (MP-SETs) are extremely rare and limited to only case reports. The aim of this study was thus to assess the feasibility of using ER for giant (≥ 6 cm) gastric MP-SETs in a case series.

methodsBetween July 2013 and December 2020, a total of 23 patients with giant (≥ 6 cm) gastric MP-SETs were treated with ER in the endoscopic center of Taizhou hospital. The study assessed outcomes of en bloc resection, complete resection, total complications, and local residual/recurrence of tumors.

resultsThe mean procedure time was 112.2 min. En bloc resection was achieved in 22 tumors (95.7%). En bloc removal from the stomach and complete resection were achieved in 6 patients (26.1%). The rate of complete resection differed significantly depending on the minimum tumor diameter (P < 0.001). During hospitalization, 4 patients had complications, including localized peritonitis (3/23, 13.0%) and pulmonary infection (1/23, 4.3%). These 4 patients recovered successfully after conservative medical treatment. Histopathological examination revealed that 18 tumors were gastrointestinal stromal tumors (GISTs), and 5 tumors were leiomyoma. No patients were observed to have residual or recurrent tumors during the follow-up.

conclusionsAlthough ER for giant (≥ 6 cm) gastric MP-SETs was associated with several technical challenges and a relatively low complete resection rate, this technique was found to be a feasible therapeutic method for selected patients with a giant (≥ 6 cm) gastric MP-SETs when performed by an experienced endoscopic team.

Indexed as

Endoscopic Mucosal ResectionGastrointestinal Stromal TumorsLaparoscopyStomach NeoplasmsFeasibility StudiesGastric MucosaGastroscopyHumansRetrospective StudiesTreatment OutcomeEndoscopic full-thickness resectionEndoscopic resectionEndoscopic submucosal dissectionGiant gastric subepithelial tumors

Identifiers

PMID35059840
OpenAlexW4205609671

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.